Remove 2019 Remove Medical Remove Safety
article thumbnail

2019 OLTUSA Schedule—Lectures, Presentations, Guidance

Online Laser Training

2019 has been a busy and productive year for OLTUSA. This 2019 OLTUSA Schedule summarizes aesthetic and medical laser events where our staff have made contributions. Denver, CO Aesthetic Show Laser Safety Compliance—Are Your Patients and Staff Safe? committees’ member Acting Secretary of ANSI Z136.3

Safety 78
article thumbnail

Increasing Rate of Medical Mistakes and Misdiagnosis

Aesthetics Advisor

Medical errors remain a leading cause of death in the U.S., 2 Describing diagnostic errors as "the most under-resourced public health crisis we face," researchers with Johns Hopkins School of Medicine said the public is largely unaware of the full scope of medical misdiagnoses in the U.S. 6 For instance, only about 1.5%

Medical 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

European Congress on Advanced Treatments and Technologies in Skin & Aesthetics

Online Laser Training

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

article thumbnail

European Congress on Advanced Treatments and Technologies in Skin & Aesthetics

Online Laser Training

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

article thumbnail

European Congress on Advanced Treatments and Technologies in Skin & Aesthetics

Online Laser Training

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

article thumbnail

FDA, EMA Accept Galderma’s BLA for Nemolizumab for PN and AD

The Dermatology Digest

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

article thumbnail

FDA Approves Galderma’s IL-31 Blocker in PN

The Dermatology Digest

Nemolizumab was granted Breakthrough Therapy Designation in December 2019 and Priority Review in February 2024 by the U.S. The phase III OLYMPIA 1 and OLYMPIA 2 clinical trials evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks in more than 500 patients with prurigo nodularis.